Premier Pharma Competitors

Elysium Pharmaceuticals Ltd is a pharmaceuticals company.

At Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), we’re igniting change in gastrointestinal (GI) medicine to develop new treatments with the potential to improve the lives of patients. Our values guide every aspect of our business—our relationships with customers, our approach to science and innovation, and our vision of a healthier future for patients. For more than 20 years, our scientists have been relentlessly committed to developing differentiated therapies for the GI market. Since the late 1990s, we have been focused on pioneering the research and development of uroguanylin analogs, a naturally occurring human GI peptide, through our clinical work. Our goal is to develop innovative treatments that improve efficacy, safety and tolerability and deliver a better experience for patients living with chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C), opioid-induced constipation (OIC), and ulcerative colitis (UC). We are committed to scientifically driven innovation, providing novel treatment options for patients and healthcare providers, rewarding opportunities for our employees, and creating exceptional value for our customers. You can find us based in New York City, with research, technical operations and commercial offices in suburban Philadelphia. Learn more about our company here: http://www.synergypharma.com/about-us You can also follow us on Twitter: @SynergyPharma

Who we are : Greenpharma is a CRO SME of 12 people, specialised in natural compound studies for cosmetic, food and pharmaceutical industries. Built around an innovative technological platform, Greenpharma succeeded to gather expertise in wide and complementary fields such as chemoinformatic, pharmacognosy, medicinal & analytical chemistry, pilot scale extraction and formulation. This has led to a unique know-how in natural compound & extract selection, extract purification, metabolite measurement, homology modelling, virtual screening (e.g. Selnergy™), lead optimisation, ADMET prediction and database building. Greenpharma approach has led to several patents on bioactive (natural or synthetic) molecules and extracts. What we do: Greenpharma provides natural or synthetic compounds for high throughput screening. It utilises in silico tools to select the most relevant molecules (we have access to a database of 20 millions commercial compounds). We provide the industries of pharmacy, cosmetics and agro-food with innovative bio-active molecules through R&D projects. Our services include: • Phytochemistry: development of methods for extraction, purification (until pilot scale) and characterisation of metabolites in complex matrices, activity-guided fractionations; • Molecular modelling: ligand and structure-based virtual screening, QSAR, in silico activity identification (eg drug repositioning, identification of activities for natural compounds...) with our proprietary tool Selnergy; • Knowledge management: database design and building. • Medicinal chemistry: synthesis on demand, lead optimisation, natural compound mimics (eg. Pyrazolotriazine...), library design... • Pilot extraction: development of pre-industrial method to produce cosmetic/food ingredients • Formulation: development of formulation for cosmetic and dermocosmetic products